Found: 14
Select item for more details and to access through your institution.
Efficacy, late complications, and cosmetic outcomes of targeted intraoperative radiotherapy in breast-conserving surgery for early-stage breast cancer: a single-centre study in China.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 12, p. 1120, doi. 10.1093/jjco/hyz128
- By:
- Publication type:
- Article
Correction to: CircNOL10 suppresses breast cancer progression by sponging miR-767-5p to regulate SOCS2/JAK/STAT signaling.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
CircNOL10 suppresses breast cancer progression by sponging miR-767-5p to regulate SOCS2/JAK/STAT signaling.
- Published in:
- Journal of Biomedical Science, 2021, v. 28, n. 1, p. 1, doi. 10.1186/s12929-020-00697-0
- By:
- Publication type:
- Article
Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. 1, doi. 10.1186/s13046-019-1470-y
- By:
- Publication type:
- Article
CircNOL10 suppresses breast cancer progression by sponging miR-767-5p to regulate SOCS2/JAK/STAT signaling.
- Published in:
- Journal of Biomedical Science, 2021, v. 28, n. 1, p. 1, doi. 10.1186/s12929-020-00697-0
- By:
- Publication type:
- Article
microRNA‐30d mediated breast cancer invasion, migration, and EMT by targeting KLF11 and activating STAT3 pathway.
- Published in:
- Journal of Cellular Biochemistry, 2018, v. 119, n. 10, p. 8138, doi. 10.1002/jcb.26767
- By:
- Publication type:
- Article
microRNA‐30d mediated breast cancer invasion, migration, and EMT by targeting KLF11 and activating STAT3 pathway.
- Published in:
- Journal of Cellular Biochemistry, 2018, v. 119, n. 10, p. 8138, doi. 10.1002/jcb.26767
- By:
- Publication type:
- Article
miR-30d suppresses proliferation and invasiveness of pancreatic cancer by targeting the SOX4/PI3K-AKT axis and predicts poor outcome.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 4, p. 1, doi. 10.1038/s41419-021-03576-0
- By:
- Publication type:
- Article
TOX high mobility group box family member 3 rs3803662 and breast cancer risk: A meta-analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A multicenter single‐arm trial of neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2‐positive breast cancer.
- Published in:
- MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.435
- By:
- Publication type:
- Article
Pyrotinib-Containing Neoadjuvant Therapy in Patients With HER2-Positive Breast Cancer: A Multicenter Retrospective Analysis.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.855512
- By:
- Publication type:
- Article
microRNA-214 enhances the invasion ability of breast cancer cells by targeting p53.
- Published in:
- International Journal of Molecular Medicine, 2015, v. 35, n. 5, p. 1395, doi. 10.3892/ijmm.2015.2123
- By:
- Publication type:
- Article
Targeted Intraoperative Radiotherapy Is Non-inferior to Conventional External Beam Radiotherapy in Chinese Patients With Breast Cancer: A Propensity Score Matching Study.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.550327
- By:
- Publication type:
- Article
Long Non-Coding RNA HULC Promotes the Development of Breast Cancer Through Regulating LYPD1 Expression by Sponging miR-6754-5p.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 10671, doi. 10.2147/OTT.S226040
- By:
- Publication type:
- Article